Nozuma S, Matsuzaki T, Tanaka M, Kodama D, Dozono M, Yoshida T
Int J Mol Sci. 2025; 26(4).
PMID: 40004169
PMC: 11855110.
DOI: 10.3390/ijms26041706.
Santana E, Dos Santos Ferreira F, Dos Santos Brito W, Lopes F, de Lima A, Neto G
Front Immunol. 2024; 15:1462352.
PMID: 39650644
PMC: 11621001.
DOI: 10.3389/fimmu.2024.1462352.
Mizuike J, Suzuki K, Tosaka S, Kuze Y, Kobayashi S, Nakashima M
Cancer Sci. 2024; 116(2):513-523.
PMID: 39561277
PMC: 11786301.
DOI: 10.1111/cas.16388.
Yang H, Arndt W, Zhang W, Mansky L
J Mol Biol. 2024; 436(24):168851.
PMID: 39505063
PMC: 11637902.
DOI: 10.1016/j.jmb.2024.168851.
Kumekawa T, Akaihata H, Natsuya H, Harigane Y, Imai H, Matsuoka K
IJU Case Rep. 2024; 7(6):438-441.
PMID: 39498183
PMC: 11531891.
DOI: 10.1002/iju5.12773.
Diagnostic Value of Anti-HTLV-1-Antibody Quantification in Cerebrospinal Fluid for HTLV-1-Associated Myelopathy.
Sato T, Yagishita N, Araya N, Nakashima M, Horibe E, Takahashi K
Viruses. 2024; 16(10).
PMID: 39459915
PMC: 11512244.
DOI: 10.3390/v16101581.
Activation of the Gene, Coding for the Catalytic Subunit of the Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) and General Transcription Factor II H, by the Trans-Activator Protein Tax of Human T-Cell Leukemia Virus Type-1.
Shirasawa M, Nakajima R, Zhou Y, Zhao L, Fikriyanti M, Iwanaga R
Genes (Basel). 2024; 15(8).
PMID: 39202439
PMC: 11353830.
DOI: 10.3390/genes15081080.
Epidemiological and clinical profile of HTLV-1 patients: a closer look at a reference center in Bahia, Brazil.
de Souza Nascimento J, Alves D, Novaes A, Ferreira Q, de Oliveira Andrade F, Silva R
Virusdisease. 2024; 35(2):243-249.
PMID: 39071874
PMC: 11269553.
DOI: 10.1007/s13337-024-00862-1.
HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load.
Tanaka M, Takenouchi N, Arishima S, Matsuzaki T, Nozuma S, Matsuura E
Int J Mol Sci. 2024; 25(13).
PMID: 38999966
PMC: 11241684.
DOI: 10.3390/ijms25136858.
Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1.
Ono M, Satou Y
Discov Immunol. 2024; 3(1):kyae006.
PMID: 38863793
PMC: 11165433.
DOI: 10.1093/discim/kyae006.
Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques.
Nakamura-Hoshi M, Ishii H, Nomura T, Nishizawa M, Hau T, Kuse N
Mol Ther. 2024; 32(7):2328-2339.
PMID: 38734900
PMC: 11286815.
DOI: 10.1016/j.ymthe.2024.05.020.
Large-Scale Whole-Genome Analysis of HTLV-1-Associated Myelopathy Identified Hereditary Spastic Paraplegias.
Takao N, Yagishita N, Araya N, Aratani S, Yamauchi J, Takahashi K
Neurol Genet. 2024; 10(1):e200108.
PMID: 38716326
PMC: 11073877.
DOI: 10.1212/NXG.0000000000200108.
Human T-cell leukemia virus type 1 uses a specific tRNA isodecoder to prime reverse transcription.
Syu Y, Hatterschide J, Budding C, Tang Y, Musier-Forsyth K
RNA. 2024; 30(8):967-976.
PMID: 38684316
PMC: 11251516.
DOI: 10.1261/rna.080006.124.
Complete Rescue of HTLV-1 Infectivity by Depletion of Monocytes Together with NK and CD8 T Cells.
Gutowska A, Sarkis S, Rahman M, Goldfarbmuren K, Moles R, Bissa M
Pathogens. 2024; 13(4).
PMID: 38668247
PMC: 11054408.
DOI: 10.3390/pathogens13040292.
Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy.
Sato T, Nagai M, Watanabe O, Misu T, Takenouchi N, Ohkubo R
J Neurol. 2024; 271(6):3471-3485.
PMID: 38430272
PMC: 11136778.
DOI: 10.1007/s00415-024-12239-x.
Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia: Insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and Japan.
Nozuma S, Yoshimura A, Pai S, Chen H, Matsuura E, Tanaka M
PLoS Negl Trop Dis. 2024; 18(2):e0011928.
PMID: 38315729
PMC: 10868808.
DOI: 10.1371/journal.pntd.0011928.
Establishment of a novel human T-cell leukemia virus type 1 infection model using cell-free virus.
Nagata K, Tezuka K, Kuramitsu M, Fuchi N, Hasegawa Y, Hamaguchi I
J Virol. 2024; 98(2):e0186223.
PMID: 38294250
PMC: 10878273.
DOI: 10.1128/jvi.01862-23.
Interaction of TSG101 with the PTAP Motif in Distinct Locations of Gag Determines the Incorporation of HTLV-1 Env into the Retroviral Virion.
Maeda Y, Monde K, Terasawa H, Tanaka Y, Sawa T
Int J Mol Sci. 2023; 24(22).
PMID: 38003710
PMC: 10671467.
DOI: 10.3390/ijms242216520.
Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma.
Yamada A, Yasunaga J, Liang L, Zhang W, Sunagawa J, Nakaoka S
Cancer Sci. 2023; 115(1):310-320.
PMID: 37950425
PMC: 10823268.
DOI: 10.1111/cas.15997.
Epidemiological and molecular evidence of intrafamilial transmission through sexual and vertical routes in Bahia, the state with the highest prevalence of HTLV-1 in Brazil.
Nunes da Silva A, Araujo T, Boa-Sorte N, Farias G, Galvao-Barroso A, de Carvalho A
PLoS Negl Trop Dis. 2023; 17(9):e0011005.
PMID: 37769013
PMC: 10593241.
DOI: 10.1371/journal.pntd.0011005.
